Literature DB >> 12690977

Pathology of pituitary tumors.

Naoko Sanno1, Akira Teramoto, R Yoshiyuki Osamura, Eva Horvath, Kalman Kovacs, Ricardo V Lloyd, Bernd W Scheithauer.   

Abstract

Pituitary adenomas are benign neoplasms originating in adenohypophysial cells. They represent the most common neoplasm of the sellar region, comprising approximately 15% of all primary intracranial tumors. Depending on the studies of unselected adult autopsy material, their frequency as an incidental finding varies between 5% and 20%. The first part of this article summarizes the immunohistochemistry of nontumorous human adenohypophysis. In the second part, the classification of pituitary tumors is discussed, followed by the immunohistochemical and electron microscopic findings of pituitary adenomas and pituitary carcinomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12690977     DOI: 10.1016/s1042-3680(02)00035-9

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  23 in total

1.  Acute visual loss and pituitary apoplexy after surgery.

Authors:  Joseph Abbott; Graham R Kirkby
Journal:  BMJ       Date:  2004-07-24

2.  Accuracy and reproducibility of a novel semi-automatic segmentation technique for MR volumetry of the pituitary gland.

Authors:  Diane M Renz; Horst K Hahn; Peter Schmidt; Jan Rexilius; Markus Lentschig; Alexander Pfeil; Dieter Sauner; Clemens Fitzek; Hans-Joachim Mentzel; Werner A Kaiser; Jürgen R Reichenbach; Joachim Böttcher
Journal:  Neuroradiology       Date:  2010-06-19       Impact factor: 2.804

Review 3.  MicroRNAs in the human pituitary.

Authors:  Milani Sivapragasam; Fabio Rotondo; Ricardo V Lloyd; Bernd W Scheithauer; Michael Cusimano; Luis V Syro; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2011-09       Impact factor: 3.943

Review 4.  Ectopic sphenoid sinus pituitary adenoma (ESSPA) with normal anterior pituitary gland: a clinicopathologic and immunophenotypic study of 32 cases with a comprehensive review of the english literature.

Authors:  Lester D R Thompson; Raja R Seethala; Susan Müller
Journal:  Head Neck Pathol       Date:  2012-03-20

5.  Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Kolja Wawrowsky; Yuji Tani; Anat Ben-Shlomo; Vladimir Ljubimov; Adam Mamelak; Serguei Bannykh; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2012-10-09

6.  MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas.

Authors:  Gail Stilling; Zhifu Sun; Shuya Zhang; Long Jin; Alberto Righi; Gábor Kovācs; Márta Korbonits; Bernd W Scheithauer; Kalman Kovacs; Ricardo V Lloyd
Journal:  Endocrine       Date:  2010-05-27       Impact factor: 3.633

7.  P53 gene mutations in pituitary carcinomas.

Authors:  Yoshinori Tanizaki; Long Jin; Bernd W Scheithauer; Kalman Kovacs; Federico Roncaroli; Ricard V Lloyd
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

Review 8.  From somatostatin to octreotide LAR: evolution of a somatostatin analogue.

Authors:  Lowell Anthony; Pamela U Freda
Journal:  Curr Med Res Opin       Date:  2009-12       Impact factor: 2.580

9.  Increased risk of preneoplastic colonic lesions and colorectal carcinoma in acromegaly: multicenter case-control study.

Authors:  Maria Florencia Battistone; Karina Miragaya; Amelia Rogozinski; Monica Agüero; Analia Alfieri; Maria Carolina Ballarino; Laura Boero; Karina Danilowicz; Sabrina Diez; Marina Donoso; Patricia Fainstein-Day; Alejandra Furioso; Natalia Garcia-Basavilbaso; Mariela Glerean; Debora Katz; Monica Loto; Susana Mallea-Gil; Marcela Martinez; Maria Isabel Sabate; Marisa Servidio; Patricia Slavinsky; Graciela Stalldecker; Soledad Sosa; Grabriela Szuman; Julieta Tkatch; Ignacio Caldo; Daniela Lubieniecki; Mirtha Guitelman
Journal:  Pituitary       Date:  2020-10-15       Impact factor: 4.107

10.  Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Tami Rubinek; Run Yu; Anat Ben-Shlomo; Kalman Kovacs; Kolja Wawrowsky; Shlomo Melmed
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.